Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartan

Objective: To evaluate drug-drug interactions (DDIs) between gefitinib or erlotinib with fluoxetine, and/or losartan. Methods: Human pooled microsomes, supersomes, and cryopreserved human hepatocytes were used to monitor DDIs in vitro. RED (Rapid Equilibrium Dialysis) protein binding was employed to...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Thu-Lan T. Luong, Michael J. McAnulty, David L. Evers, Brian J. Reinhardt, Peter J. Weina
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2021-01-01
Serija:	Current Research in Toxicology
Teme:	Drug-Drug Interaction Erlotinib Gefitinib Fluoxetine Losartan Cytochrome P450
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2666027X21000232
Oznake:	Označite Brez oznak, prvi označite!